Deborah K Armstrong

8PUBLICATIONS
101CO-AUTHORS
Molecular targetsCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 14, 2026
Phase II Study of Dabrafenib and Trametinib in Patients With Tumors With BRAFV600E Mutations: Updated Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol H.

April K S Salama, Victoria Wang, Erin R Macrae

|Feb 28, 2025
Germline-Somatic Interactions in BRCA-Associated Cancers: Unique Molecular Profiles and Clinical Outcomes Linking ATM to TP53 Synthetic Essentiality.

Ali T Arafa, Siddhartha Yadav, Catherine H Marshall

|Feb 12, 2025
Cancer Susceptibility Gene Testing in Patients With Pancreatic Ductal Adenocarcinoma: Implementation in a Cancer Center Oncology Clinic.

Hassan Sinan, Dea Cunningham, Emy Abou Sleiman

|Jan 22, 2025
Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update.

Stéphanie Gaillard, Christina Lacchetti, Deborah K Armstrong

|Apr 25, 2023
Combination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) Trial in Acquired PARP Inhibitor-Resistant Homologous Recombination-Deficient Ovarian Cancer.

Stephanie L Wethington, Payal D Shah, Lainie Martin

|Mar 02, 2023
Phase I Trial of Intravenous Mistletoe Extract in Advanced Cancer.

Channing J Paller, Lin Wang, Wei Fu

Pageof 2

Frequent Collaborators

3 joint publications

Stephanie Gaillard

2 joint publications

Kala Visvanathan

2 joint publications

Daniel Laheru

2 joint publications

Nilofer S Azad